載入...
Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies
BACKGROUND: Dual antiplatelet therapy (DAPT) in the form of aspirin plus a P(2)Y(12) inhibitor, when indicated, is one of the key treatments in coronary artery disease (CAD). Many recommendations on DAPT in patients with CAD based on current guidelines are largely inconsistent. In our current study,...
Na minha lista:
| 發表在: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley Periodicals, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906997/ https://ncbi.nlm.nih.gov/pubmed/31609463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23275 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|